NDC11 51316083701
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 51316-0837-01 | 51316-0837 |
| 51316-0837-1 | 51316-0837 |
| 51316-837-01 | 51316-837 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| CVS Maximum Redness Relief | GLYCERIN, NAPHAZOLINE HCI | CVS Pharmacy, Inc. | f70f9fc4-4022-336e-e053-6394a90a4d07 | 2025-12-30 | Warnings | 51316-837-01 51316-837 51316083701 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.